About Us
Our Pharma Quality Standards
About Us
Management Team
Board of Directors
Science Advisory Committee
Strategic Alliances
Science of Extraction
COVID-19
Virtual Tour
Products & Services
White Label Production
Bulk Wholesale Offerings
MediPharm Brand
LABS Cannabis
Wayfarer
News
Press Releases
Blog
Events
In The News
Investors
Overview
News / Events
Company Information
Stock Data
Financial Results
SEDAR
Corporate Governance
Contact
Contact Us
Careers
Customer Service
Australia
Search
A Global Leader in Pharma-Quality, Cannabinoid-Based Products
Financial Results
Investors
Investors
Overview
News / Events
Overview
Annual Meeting
Press Releases
Events Calendar
Email Alerts
Company Info
Overview
Presentations
Management Team
Board of Directors
Science Advisory Committee
Contacts
FAQ
Stock Data
TSX: LABS
OTCQX: MEDIF
Deutsche Börse: MLZ
Analyst Coverage
Financial Results
SEDAR
Governance
Overview
Board Committees
Governance Documents
2020
Q3 2020
Quarter Ended Sep 30, 2020
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
Q2 2020
Quarter Ended Jun 30, 2020
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
Q1 2020
Quarter Ended Mar 31, 2020
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
2019
FY 2019
Fiscal Year Ended Dec 31, 2019
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
PDF
AIF
Q3 2019
Quarter Ended Sep 30, 2019
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
Q2 2019
Quarter Ended Jun 30, 2019
PDF
HTML
Earnings Release
Audio
Earnings Webcast
PDF
Financial Statements
PDF
MD&A
Q1 2019
Quarter Ended Mar 31, 2019
PDF
HTML
Earnings Release
PDF
Financial Statements
PDF
MD&A
2018
FY 2018
Fiscal Year Ended Dec 31, 2018
Annual Report
PDF
HTML
Earnings Release
PDF
Financial Statements
PDF
MD&A
PDF
Annual Report
Q3 2018
Quarter Ended Sep 30, 2018
PDF
Financial Statements
Email Alerts
RSS News Feed